World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00279500
Date of registration: 17/01/2006
Primary sponsor: Second Sight Medical Products
Public title: Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Scientific title: Chronic Retinal Electrodes to Provide Electrical Stimulation of the Retina to Elicit Visual Percepts in Blind Subjects
Date of first enrolment: February 2002
Target sample size: 6
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT00279500
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Lisa Olmos, MD
Address: 
Telephone:
Email:
Affiliation:  Doheny Eye Institute
Key inclusion & exclusion criteria

Inclusion Criteria:

- Confirmed history of retinal degenerative disease in the worse seeing eye with
remaining vision no better than light perception. The fellow eye can have any visual
acuity but must have better vision than the eye that will have the surgery.

- History of former useful form vision in worse-seeing eye

- Acceptable ability to describe visual percepts

- Age eighteen (18) or older

Exclusion Criteria:

- History of glaucoma

- Optic neuropathy or other confirmed damage to optic nerve or visual cortical damage

- Presence of communicable disease/infection

- Pregnancy

- History of claustrophobia

- Inconsistent flash detection thresholds

- Any other diseases that can effect the function of the retina

- Subjects with a Beck Depression Inventory Interpretation score of >30 and subsequent
diagnosis of depression by a psychiatrist.

- Corneal degeneration



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Retinitis Pigmentosa
Intervention(s)
Device: Argus 16 Retinal Stimulation System
Primary Outcome(s)
Ability to resolve multiple percepts and patterns. [Time Frame: From 2 weeks post-op until end of device usage]
Medical and surgical risk as a result of device usage. [Time Frame: From 2 weeks post-op until end of device usage]
Optimize effectiveness of stimulus parameters. [Time Frame: From 2 weeks post-op until end of device usage]
Subject risk as a result of chronic electrical stimulation. [Time Frame: From 2 weeks post-op until end of device usage]
Secondary Outcome(s)
Secondary ID(s)
CP0002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history